<b>Conclusions:</b> This study identifies <i>CD19</i>, <i>MTPAP</i>, and <i>PER3</i> as promising peripheral blood biomarkers for MDD, with potential implications for early diagnosis, severity assessment, and personalized treatment strategies. The gene discussed is CD19; the disease is major depressive disorder.